Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
IES Holdings
IESC
$14.9B
| $6.91M | ﹤0.01% |
87,243
+9,463
| +12% | +$660K |
|
2177
Emergent Biosolutions
EBS
$230M
| $6.9M | ﹤0.01% |
2,873,984
+1,312,934
| +84% | +$3.09M |
|
2178
LendingTree
TREE
$461M
| $6.89M | ﹤0.01% |
227,302
+11,753
| +5% | +$213K |
|
|
GDEN
2179
DELISTED
Golden Entertainment
GDEN
| $6.88M | ﹤0.01% |
172,204
+4,220
| +3% | +$153K |
|
2180
VSE Corp
VSEC
$6.48B
| $6.86M | ﹤0.01% |
106,229
+6,447
| +6% | +$379K |
|
2181
BRC Group Holdings
RILY
$303M
| $6.85M | ﹤0.01% |
326,428
+49,973
| +18% | +$1.46M |
|
2182
Vertex
VERX
$2.15B
| $6.81M | ﹤0.01% |
252,869
+30,194
| +14% | +$774K |
|
2183
ATN International
ATNI
$491M
| $6.77M | ﹤0.01% |
173,768
+12,401
| +8% | +$410K |
|
2184
FIGS
FIGS
$2.47B
| $6.76M | ﹤0.01% |
972,788
+18,056
| +2% | +$119K |
|
2185
Zentalis Pharmaceuticals
ZNTL
$297M
| $6.75M | ﹤0.01% |
445,823
+3,759
| +0.9% | +$54.8K |
|
2186
The RMR Group
RMR
$346M
| $6.75M | ﹤0.01% |
239,218
+39,270
| +20% | +$959K |
|
2187
First Advantage
FA
$3.81B
| $6.74M | ﹤0.01% |
406,641
+8,958
| +2% | +$131K |
|
2188
Univest Financial
UVSP
$1.19B
| $6.68M | ﹤0.01% |
303,331
+2,784
| +0.9% | +$52.2K |
|
|
ACCD
2189
DELISTED
Accolade Inc
ACCD
| $6.68M | ﹤0.01% |
555,982
+34,559
| +7% | +$296K |
|
|
BELFB
2190
Bel Fuse Inc Class B
BELFB
$4.13B
| $6.66M | ﹤0.01% |
99,716
+21,047
| +27% | +$1.13M |
|
2191
Kanzhun
BZ
$6.89B
| $6.65M | ﹤0.01% |
400,244
-25,231
| -6% | -$396K |
|
2192
Mission Produce
AVO
$1.15B
| $6.64M | ﹤0.01% |
658,038
+59,983
| +10% | +$557K |
|
2193
Alto Ingredients
ALTO
$326M
| $6.63M | ﹤0.01% |
2,494,032
+413,116
| +20% | +$1.32M |
|
2194
Virgin Galactic
SPCE
$475M
| $6.63M | ﹤0.01% |
135,354
+17,465
| +15% | +$689K |
|
2195
Powell Industries
POWL
$7.43B
| $6.62M | ﹤0.01% |
224,694
+3,099
| +1% | +$86.3K |
|
|
DAWN
2196
DELISTED
Day One Biopharmaceuticals
DAWN
| $6.61M | ﹤0.01% |
452,934
+5,796
| +1% | +$70.3K |
|
|
LPRO
2197
DELISTED
Open Lending Corp
LPRO
| $6.61M | ﹤0.01% |
776,264
+9,957
| +1% | +$67K |
|
|
FBMS
2198
DELISTED
The First Bancshares, Inc.
FBMS
| $6.56M | ﹤0.01% |
223,675
-520
| -0.2% | -$13.9K |
|
2199
Yext
YEXT
$613M
| $6.53M | ﹤0.01% |
1,108,423
+186,838
| +20% | +$1.15M |
|
2200
Shell
SHEL
$248B
| $6.49M | ﹤0.01% |
98,706
+26,729
| +37% | +$1.75M |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.